Octreoscan radioreceptor imaging.

作者: Aart J. van der Lely , Wouter W. de Herder , Eric P. Krenning , Dik J. Kwekkeboom

DOI: 10.1385/ENDO:20:3:307

关键词:

摘要: With the in vivo demonstration of somatostatin-receptor-positive tumors patients using a radiolabeled somatostatin analog, peptide receptor scintigraphy became available some 15 yr ago. Octreoscan® is radiopharmaceutical with proven clinical importance visualization tumors, and overall sensitivity imaging high. In number neuroendocrine tumor types, as well Hodgkin’s disease, inclusion localization or staging procedure may be very rewarding. The value other like breast cancer, granulomatous diseases, has to established.

参考文章(59)
Jean Reubi, Beatrice Waser, Jean-Claude Schaer, Jean A. Laissue, Somatostatin receptor sst1–sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 28, pp. 836- 846 ,(2001) , 10.1007/S002590100598
Olivier Mundler, Pierre-Jean Guillausseau, Michèle Duet, André Warnet, Boris Lormeau, Elisabeth Lajeunie, Vincens Rohmer, Didier Vilain, Salah Benelhadj, Christiane Ajzenberg, Somatostatin Receptor Scintigraphy in Pituitary Adenomas: A Somatostatin Receptor Density Index Can Predict Hormonal and Tumoral Efficacy of Octreotide In Vivo The Journal of Nuclear Medicine. ,vol. 40, pp. 1252- 1256 ,(1999)
Jean Claude Reubi, Luca Mazzucchelli, Jean A. Laissue, Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease Gastroenterology. ,vol. 106, pp. 951- 959 ,(1994) , 10.1016/0016-5085(94)90754-4
R. Lebtahi, D. Le Guludec, L. Sarda, D. Daou, Y. Petegnief, M. Mignon, M. Faraggi, G. Cadiot, Clinical Impact of Somatostatin Receptor Scintigraphy in the Management of Patients with Neuroendocrine Gastroenteropancreatic Tumors The Journal of Nuclear Medicine. ,vol. 38, pp. 853- 858 ,(1997)
T Reisine, K Raynor, Anne-Marie O'Carroll, Stephen J Lolait, Characterization of cloned human somatostatin receptor SSTR5. Molecular Pharmacology. ,vol. 46, pp. 291- 298 ,(1994)
Fathia Gibril, Stephan U. Goebel, John L. Doppman, Clara C. Chen, Robert T. Jensen, Fang Yu, Jose Serrano, James C. Reynolds, Specificity of somatostatin receptor scintigraphy: a prospective study and effects of false-positive localizations on management in patients with gastrinomas. The Journal of Nuclear Medicine. ,vol. 40, pp. 539- 553 ,(1999)
Rachida Lebtahi, Claire Houzard, Joseph Le Cloirec, Iradj Sobhani, Patrick Bourguet, Doumit Daou, Dominique Le Guludec, Michel Mignon, Geneviève Sassolas, Detection of Neuroendocrine Tumors: 99mTc-P829 Scintigraphy Compared with 111In-Pentetreotide Scintigraphy The Journal of Nuclear Medicine. ,vol. 43, pp. 889- 895 ,(2002)
P.T.E. Postema, W.W. de Herder, J.C. Reubi, H.Y. Oei, D.J. Kwekkeboom, H.J. Bruining, J. Bonjer, H. van Toor, G. Hennemann, E.P. Krenning, Somatostatin Receptor Scintigraphy in Non-Medullary Thyroid Cancer Digestion. ,vol. 57, pp. 36- 37 ,(1996) , 10.1159/000201391
M Phlipponneau, M Nocaudie, J Epelbaum, Y De Keyzer, J D Lalau, X Marchandise, X Bertagna, Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. The Journal of Clinical Endocrinology and Metabolism. ,vol. 78, pp. 20- 24 ,(1994) , 10.1210/JCEM.78.1.7904613
J.C. Reubi, E. Krenning, S.W.J. Lamberts, L. Kvols, In vitro detection of somatostatin receptors in human tumors. Metabolism-clinical and Experimental. ,vol. 41, pp. 104- 110 ,(1992) , 10.1016/0026-0495(92)90042-9